CynosBio, Inc. CynosBio, Inc.

Blurry image of a hallway with several people walking through, creating a sense of movement and activity.

Regenerative Medicine
For The Future

A panoramic view of a city skyline under a clear blue sky.

MISSION

We, CynosBio, are a venture company that can complete research, development, manufacturing and marketing of regenerative medicine products in-house.

OUR MISSION

PIPELINE

A person in a lab coat holds a test tube, demonstrating a scientific experiment in a laboratory setting.

Sakracy

Human (autologous) oral mucosa-derived epithelial cell sheet using human amniotic membrane substrate

In February 2023, we launched Sakuracy® as a designated regenerative medicine product indicated for reducing adhesion of the ocular surface in Limbal Stem Cell Deficiency.

A person in a lab coat holds a test tube, demonstrating a scientific experiment in a laboratory setting.
See more information
A person in a lab coat holds a test tube, focused on their work in a laboratory setting.

IK-01

Collagen gel matrix involved autologous cultivated chondrocyte

IK-01 is a regenerative medicine product that promotes the regeneration of autologous chondrocytes by transplanting it into damaged areas of the knee cartilage, with the aim of repairing damage and inhibiting the progression of osteoarthritis. We are currently conducting a Phase III clinical trial targeting osteoarthritis of the knee.

A person in a lab coat holds a test tube, focused on their work in a laboratory setting.
See more information

ABOUT US

ANNOUNCEMENTS

See list
See list